Abbott Laboratories Inc.

Abbott Laboratories Inc., through its Abbott Diagnostics Division operating as Abbott Nutrition, supplies clinical laboratory analyzers, reagents, consumables, and diagnostic testing services to federal healthcare agencies as a prime contractor competing under full and open competition without small business set-asides. The company is a large for-profit manufacturer headquartered in Lake Bluff, Illinois, with a corporate parent structure and subsidiary Abbott Molecular Inc.

Abbott's federal footprint centers on cost-per-reportable-result (CPRR) chemistry and immunoassay analyzer systems, blood product screening reagents, infectious disease testing capabilities, and associated clinical laboratory consumables. Representative recent awards include a $9.13 million delivery order from the Department of Veterans Affairs Veterans Integrated Service Network 22 for a Chemistry Immunoassay System (July 2026); a $7.14 million delivery order from VISN 20 for cost-per-reportable-result laboratory supplies under the GSA Critical Analyzers, Laboratory schedule (July 2026); a $2.88 million delivery order from the Indian Health Service for an Integrated Chemistry System for Federal Hospitals (November 2024); and a $2.353 million definitive contract from the Defense Health Agency for chemistry and immunochemistry analyzers, reagents, and supplies (November 2024). The company also performs maintenance and support work—a $803 thousand purchase order from CDC Pittsburgh for five-year Alinity analyzer maintenance and supplies (June 2026) exemplifies this capability segment.

Customer concentration reflects Abbott's dominance in federal clinical laboratory procurement. The top five funding agencies by potential value—VISN 15, VISN 9, VISN 1, VISN 8, and VISN 7—account for significant shares, with VISN 15 and VISN 9 alone carrying $408.2 million and $386.3 million combined potential value respectively. By award count, the Defense Logistics Agency Troop Support Medical leads with 1,931 awards, but the Department of Veterans Affairs dominates by dollar magnitude across its regional networks. Abbott serves 119 distinct federal customer agencies, with the VA, Indian Health Service, Defense Health Agency, Department of Justice (Federal Correctional Complex Butner), and NIH Clinical Center as recurring customers.

Abbott holds multiple parent vehicle positions anchoring its federal work. The GSA Critical Analyzers, Laboratory (FSS-66-III) schedule carries 1,230 task orders valued at $1.62 billion in combined potential value—Abbott's primary vehicle across all federal health customers. Abbott also maintains multiple single-award Blanket Purchase Agreements and Indefinite Delivery Contracts with individual VISNs: a $56.4 million BPA with VISN 9 for immunochemistry laboratory cost-per-reportable-result services through September 2033; a $15.9 million BPA with VISN 2 for chemistry and immunoassay CPRR through March 2027; an $8.26 million BPA with VISN 5 for CPRR chemistry through June 2031; a $17.75 million BPA with VISN 23 for chemistry lab testing through June 2027; a $7.5 million BPA with VISN 10 for chemistry and immunoassay CPRR through February 2030; and a $4.78 million indefinite delivery contract with VISN 22 for chemistry and immunoassay systems through August 2030. GSA schedules V797P4742A and V797P5478X rank as secondary vehicle anchors, each carrying 2,700-plus task orders worth $350-370 million combined.

Activity shows sustained engagement at roughly 130-160 awards per year over the past five years, with 87 awards (combined potential value $98.4 million) reaching completion within the next twenty-four months and therefore facing recompete exposure. Abbott's capability portfolio reflects its product line: Architect and Alinity analyzer platforms for chemistry and immunoassay work, i-STAT wireless point-of-care analyzers, specialized reagents for infectious disease and blood product screening, and associated consumables dominate the contract descriptions. Primary NAICS categories are Medical Laboratories (3,033 awards), In-Vitro Diagnostic Substance Manufacturing (2,925 awards), and Analytical Laboratory Instrument Manufacturing (1,535 awards); top PSC categories align with laboratory equipment, diagnostic reagents, and medical instruments.

Abbott subcontracts minimally—only 109 of 12,540 awards are sub-awards, all routed through Cardinal Health 200 LLC, the distributor/logistics prime, as sub-level supplier of surgical implants and medical devices (pacemakers, cardiac sensors, electrode kits) not directly aligned with Abbott Diagnostics' clinical laboratory core. Abbott's federal posture reflects a mature, unrestricted prime contractor position focused on civilian federal healthcare procurement, with no set-aside activity and dominant presence in VA regional networks where cost-per-reportable-result contracts align with the agency's laboratory infrastructure modernization and operational efficiency priorities.